or Try an Advanced Search...

    Technical Analysis for TNGX - Tango Therapeutics

    Grade Last Price % Change Price Change
    C 9.00 4.90% 0.42
    TNGX closed up 4.9 percent on Monday, July 1, 2024, on 69 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Down
    Historical TNGX trend table...
    Date Alert Name Type % Chg
    MACD Bearish Signal Line Cross Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    Pocket Pivot Bullish Swing Setup 4.90%
    Spinning Top Other 4.90%
    Volume Surge Other 4.90%
    NR7 Range Contraction 4.90%
    Narrow Range Bar Range Contraction 4.90%
    Wide Bands Range Expansion 4.90%
    Wide Bands Range Expansion 5.39%
    Down 3 Days in a Row Weakness 5.39%
    Older End-of-Day Signals for TNGX ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 9 hours ago
    60 Minute Opening Range Breakout about 9 hours ago
    Up 2% about 10 hours ago
    Rose Above Previous Day's High about 10 hours ago
    Down 1% about 10 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    TNGX Chart by TradingView
    Basic chart:

    Profile

    Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Life Sciences Biology Treatment Of Cancer Tumor Genetics Medical Genetics Applied Genetics Synthetic Lethality Oncogenomics

    Is TNGX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 5 Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
    May 23 Medivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program
    May 23 Tango Therapeutics to discontinue development of TNG348 program
    May 23 Tango Therapeutics Announces Discontinuation of TNG348 Program
    May 8 Tango Therapeutics Q1 GAAP EPS of -$0.35 misses by $0.04
    May 8 Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
    Mar 20 Tango Therapeutics Inc (TNGX) Reports Full Year and Q4 2023 Financial Results
    Mar 18 Tango Therapeutics GAAP EPS of -$0.32 misses by $0.04, revenue of $5.43M misses by $2.81M
    Mar 18 Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights
    Mar 6 Tango Therapeutics to Participate in Upcoming Investor Conferences
    See more TNGX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 13.03
    52 Week Low 2.88
    Average Volume 687,294
    200-Day Moving Average 9.07
    50-Day Moving Average 7.82
    20-Day Moving Average 8.38
    10-Day Moving Average 9.30
    Average True Range 0.60
    RSI (14) 57.45
    ADX 27.71
    +DI 27.60
    -DI 20.13
    Chandelier Exit (Long, 3 ATRs) 8.64
    Chandelier Exit (Short, 3 ATRs) 8.26
    Upper Bollinger Bands 10.56
    Lower Bollinger Band 6.20
    Percent B (%b) 0.64
    BandWidth 52.07
    MACD Line 0.43
    MACD Signal Line 0.43
    MACD Histogram -0.005
    Fundamentals Value
    Market Cap 917.91 Million
    Num Shares 102 Million
    EPS -1.11
    Price-to-Earnings (P/E) Ratio -8.11
    Price-to-Sales 33.75
    Price-to-Book 4.48
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.80
    Resistance 3 (R3) 9.71 9.37 9.66
    Resistance 2 (R2) 9.37 9.16 9.41 9.62
    Resistance 1 (R1) 9.18 9.04 9.28 9.27 9.57
    Pivot Point 8.84 8.84 8.88 8.88 8.84
    Support 1 (S1) 8.65 8.63 8.75 8.74 8.43
    Support 2 (S2) 8.31 8.51 8.35 8.38
    Support 3 (S3) 8.12 8.31 8.34
    Support 4 (S4) 8.21